(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

CELLISTIC

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: CombinedOffice: United States

Quick snapshot

CELLISTIC

ST13

US500000079376806

Class

42

Filing

79376806

Registration

7636669

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

38

Latest update

04/03/2026

Trademark type

Combined

Nice classes

42

Filing date

07/10/2023

Registration date

01/07/2025

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

01/07/2025

Last transaction

04/03/2026

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Drawing code

3

Owner type

98

Owner location

BE

Examiner

GIBBONS, BRIAN R

Law office

L60

Current location

FILE REPOSITORY (FRANCONIA)

Mark description

The mark consists of the following: a purple circle made of lines with a white diamond in the center, and the black wording CELLISTIC.

Holders and representatives

Holders

Celyntra Therapeutics SA
Cellistic SA
Ncardia B.V.

Representatives

Cellistic SA

Technical classification

Nice Classes

Class 42

Vienna Codes

No Vienna codes available.

Goods and services

Class 42

Laboratory research in the field of biopharmaceuticals; laboratory research in the field of biotechnology; biotechnology research and testing; development of new technology for others in the field of biotechnology; scientific research on stem cells; scientific research on the production and differentiation of pluripotent stem cells; research and development in the field of stem cellscell therapy and biotechnology; pharmaceutical research and development; scientific laboratory services; providing information with respect to scientific research in the field of stem cellscell and gene therapy and biotechnology; product research and development for the pharmaceutical industry; technological consultancy in the field of biotechnology; technological consultancy in the field of biotechnology for the pharmaceutical industry; new biopharmaceutical product design services; new product design services for the pharmaceutical industry; industrial analysis of pharmaceuticals; pharmaceutical research services; biopharmaceutical research and development; research and development of new biopharmaceutical products for others; biopharmaceuticals product development consultation; scientific research consultancy; scientific research consultancy in the field of pharmaceuticals; none of the foregoing for design and development of products in the field of computer hardware

Publications

History of USPTO decisions and trademark events.

38 publications found

CHLD

CHANGE OF OWNER RECEIVED FROM IB

03/12/2026

FINO

FINAL DECISION TRANSACTION PROCESSED BY IB

07/26/2025

FICS

FINAL DISPOSITION NOTICE SENT TO IB

07/04/2025

FIMP

FINAL DISPOSITION PROCESSED

07/04/2025

FICR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

04/07/2025

OPNX

NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB

02/01/2025

OPNS

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

01/15/2025

OPNR

NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB

01/15/2025

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

01/07/2025

R.PR

REGISTERED-PRINCIPAL REGISTER

01/07/2025

PUBO

PUBLISHED FOR OPPOSITION

11/19/2024

NPUB

NOTICE OF PUBLICATION

11/13/2024

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

10/11/2024

CHLD

CHANGE OF OWNER RECEIVED FROM IB

10/11/2024

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

10/10/2024

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

10/10/2024

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

10/10/2024

NREP

NEW REPRESENTATIVE AT IB RECEIVED

08/10/2024

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

08/07/2024

ECDR

TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS

08/07/2024

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

08/07/2024

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

08/07/2024

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

07/10/2024

ECDR

TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS

07/10/2024

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

07/10/2024

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

07/10/2024

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

07/10/2024

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

07/10/2024

RFNT

REFUSAL PROCESSED BY IB

05/08/2024

RFCS

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

04/12/2024

RFRR

REFUSAL PROCESSED BY MPU

04/11/2024

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

03/24/2024

CNRT

NON-FINAL ACTION WRITTEN

03/23/2024

DOCK

ASSIGNED TO EXAMINER

03/19/2024

NREP

NEW REPRESENTATIVE AT IB RECEIVED

12/30/2023

MAFR

APPLICATION FILING RECEIPT MAILED

08/22/2023

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

08/18/2023

REPR

SN ASSIGNED FOR SECT 66A APPL FROM IB

08/17/2023

Continuous trademark protection

Get notified about every new filing that threatens CELLISTIC or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.